睾丸肾上腺残余肿瘤的纵向特征与超声分期
75%发生睾丸肾上腺残余肿瘤(TART),平均起病年龄13.6±4.9岁,约22%在10岁前已有风险。失盐型、较高氢化可的松等效剂量及ACTH升高与TART风险增加相关,并提出了超声进展分期。
要点
- 经典CAH男性TART常见,75%在随访中发生,平均起病年龄13.6±4.9岁。
- 失盐型、较高氢化可的松等效剂量及ACTH升高与TART风险增加独立相关。
- 超声显示TART从单发低回声结节进展为多发结节再到睾丸纵隔旁融合团块,建议儿童期筛查。
核心结论
- 经典CAH男性TART常在青春期前发生,并呈现特征性超声进展模式,据此提出放射学分期。
- 失盐型表型/基因型、较高氢化可的松等效剂量及ACTH升高与TART风险增加相关。
- 建议对经典CAH男性进行儿童期超声筛查,尤其失盐型者。
研究设计与样本
- 采用生存分析和纵向模型确定TART起病年龄及进展相关因素。
主要发现
- TART presence与ACTH、17-羟孕酮、雄烯二酮、血浆肾素活性升高、诊断年龄较小、失盐型及null/In2G突变相关。
- 多变量分析显示失盐型(OR 6.83,95%CI 2.36-19.77;P<.001)、较高氢化可的松等效剂量(OR 1.10,95%CI 1.03-1.18;P=.006)及ACTH升高(OR 1.0011,95%CI 1.0005-1.0017;P<.01)增加任一次访视时TART风险。
- 末次访视时19例TART患者氢化可的松等效剂量为16.0±7.9 mg/m2/天,低于TART消退者的21.3±7.5 mg/m2/天。
- 系列超声显示TART从单发低回声结节进展为多发低回声结节,再进展为睾丸纵隔旁单发融合团块。
关键数值与推荐
- TART起病平均年龄13.6±4.9岁,约22%在10岁前已有风险。
- 失盐型OR 6.83(95%CI 2.36-19.77;P<.001)。
- 较高氢化可的松等效剂量OR 1.10(95%CI 1.03-1.18;P=.006)。
- ACTH升高OR 1.0011(95%CI 1.0005-1.0017;P<.01)。
临床怎么用
- 对经典CAH男性,尤其失盐型/基因型者,应从儿童期开始定期阴囊超声筛查TART。
- 随访中关注ACTH、17-羟孕酮、雄烯二酮及肾素活性,综合评估TART风险。
- 超声发现睾丸内低回声结节或融合团块时,应按 proposed 放射学分期描述并监测进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Testicular adrenal rest tumors (TART) frequently develop and are the most common cause of male infertility in classic congenital adrenal hyperplasia (CAH). Little is known about the natural course. OBJECTIVE: We aimed to investigate age of onset and associated factors and characterize the sonographic natural history of TART in males with classic CAH followed prospectively from childhood to adulthood. METHODS: Longitudinal study of clinical and hormonal data and serial scrotal ultrasounds performed every 6 months during childhood and annually in adulthood. Survival analysis and longitudinal models were used to determine age of TART onset and factors associated with TART progression. RESULTS: Seven hundred eighty-three ultrasounds from 36 males were evaluated. Twenty-seven (75%) developed TART; the mean age of onset was 13.6 ± 4.9 years, with ∼22% risk before age 10. TART presence was associated with elevated ACTH, 17-hydroxyprogesterone, androstenedione, and plasma renin activity, younger age at diagnosis, salt-wasting (SW) phenotype, and null/In2G mutations. Multivariable analysis revealed SW phenotype [odds ratio (OR): 6.83, 95% confidence interval (CI) 2.36-19.77; P < .001], treatment with higher hydrocortisone dose equivalents (OR: 1.10, 95% CI 1.03-1.18; P = .006), and elevated ACTH (OR: 1.0011, 95% CI 1.0005-1.0017; P < .01) increased risk of TART at any given visit. Of 19 patients with TART at last visit, the hydrocortisone dose equivalent was 16.0 ± 7.9 mg/m2/day, lower than 21.3 ± 7.5 mg/m2/day observed in patients whose TARTs resolved. Serial sonograms showed a characteristic pattern of TART progression from a single hypoechoic nodule to multiple hypoechoic nodules to a single conglomerate mass near the mediastinum testis. CONCLUSION: TART formation in CAH is frequently found in prepubertal boys, with a characteristic pattern of development resulting in a proposed radiologic staging. Pediatric screening is recommended, especially in those with a SW phenotype/genotype.
引用
- Vaid S, Kulkarni S, Marko J, et al. Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors. J Clin Endocrinol Metab. 2026. PMID: 40921717. doi:10.1210/clinem/dgaf498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。